Literature DB >> 23251181

Persistent Inflammation in Pulmonary Granuloma 48 Years after Talcage Pleurodesis, Detected by FDG-PET/CT.

J C Fanggiday1, R W Rouse, S M Collard, M J de Haas, J M H de Klerk.   

Abstract

In patients with suspicion of lung malignancy, FDG PET/CT is frequently used as a diagnostic and staging imaging modality. However, false positive findings are not uncommon. We demonstrate a case with FDG-avid pulmonary nodules, mimicking lung cancer. After histopathological examination they appeared to be the result of persistent inflamed tissue, due to talcage pleurodesis, which occurred 48 years ago. We concluded that, nearly five decades after talcage pleurodesis, there can still be an ongoing inflammation reaction in the pleurae, which can be detected by FDG PET/CT.

Entities:  

Year:  2012        PMID: 23251181      PMCID: PMC3509450          DOI: 10.1155/2012/686153

Source DB:  PubMed          Journal:  Case Rep Med


  11 in total

1.  CT appearance of the pleural space after talc pleurodesis.

Authors:  J G Murray; E F Patz; J J Erasmus; R C Gilkeson
Journal:  AJR Am J Roentgenol       Date:  1997-07       Impact factor: 3.959

2.  Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography.

Authors:  J G Murray; J J Erasmus; E A Bahtiarian; P C Goodman
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

3.  Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis.

Authors:  G R Jones
Journal:  Thorax       Date:  1969-01       Impact factor: 9.139

Review 4.  Talc pleurodesis for the treatment of pneumothorax and pleural effusion.

Authors:  L Kennedy; S A Sahn
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

5.  Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax.

Authors:  S Györik; S Erni; U Studler; R Hodek-Wuerz; M Tamm; P N Chhajed
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

6.  Talc preparations used for pleurodesis vary markedly from one preparation to another.

Authors:  J Ferrer; M A Villarino; J M Tura; A Traveria; R W Light
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

7.  F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.

Authors:  Nghi C Nguyen; Isaac Tran; Christopher N Hueser; Dana Oliver; Hussein R Farghaly; Medhat M Osman
Journal:  Clin Nucl Med       Date:  2009-12       Impact factor: 7.794

Review 8.  Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax?

Authors:  Ian Hunt; Brendan Barber; Rachel Southon; Tom Treasure
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-11-22

9.  Pleural FDG Uptake More Than a Decade after Talc Pleurodesis.

Authors:  Hilke Peek; Wouter van der Bruggen; Gijs Limonard
Journal:  Case Rep Med       Date:  2009-07-30

Review 10.  Inflammation and clinical repercussions of pleurodesis induced by intrapleural talc administration.

Authors:  Eduardo Henrique Genofre; Evaldo Marchi; Francisco S Vargas
Journal:  Clinics (Sao Paulo)       Date:  2007-10       Impact factor: 2.365

View more
  3 in total

1.  Talc Pleurodesis With Intense 18F-FDG Activity But No 68Ga-DOTA-TATE Activity on PET/CT.

Authors:  Georgios Z Papadakis; Corina Millo; Ulas Bagci; Nicholas J Patronas; Constantine A Stratakis
Journal:  Clin Nucl Med       Date:  2015-10       Impact factor: 7.794

2.  Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis.

Authors:  Marcus Paulo Fernandes Amarante; Riad Naim Younes; Letícia Rigo; Marcelo Rocha de Sousa Cruz
Journal:  Ecancermedicalscience       Date:  2014-08-12

Review 3.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.